Acadia Pharmaceuticals (ACAD) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$1.1B

Revenue (quarter)

$308.0M

Revenue growth (year over year)

+16.40%

Gross profit (trailing twelve months)

$1.0B

Gross margin

91.13%

Net income (trailing twelve months)

$380.5M

Net income (quarter)

$31.5M

Net income growth (year over year)

+18.13%

Net margin

33.42%

Return on equity

35.74%

EPS (trailing twelve months)

$2.26

Book value per share

$7.59

P/E (trailing twelve months)

8.43

Price to book

2.46

Debt to assets

25.03%

Payout ratio

—

Dividend yield

—

Company profile

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world. It has two franchises in neurological and rare diseases. Its neurological disease franchise is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. FDA for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

• Is Acadia Pharmaceuticals (ACAD) profitable?

  Yes. Acadia Pharmaceuticals earned $380.5M in net income over the trailing twelve months, a net margin of 33.42%.

• How much revenue does Acadia Pharmaceuticals (ACAD) make?

  Acadia Pharmaceuticals generated $1.1B in revenue over the trailing twelve months, up 16.40% year over year.

• What is ACAD's P/E ratio?

  Acadia Pharmaceuticals trades at 8.4 times trailing twelve-month earnings, on an EPS of $2.26.

• How do I buy stock in Acadia Pharmaceuticals (ACAD)?

  ACAD trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.